Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-311219
Filing Date
2025-12-08
Accepted
2025-12-08 16:07:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d79646d424b5.htm 424B5 484369
2 GRAPHIC g79646g00g03.jpg GRAPHIC 52420
  Complete submission text file 0001193125-25-311219.txt   557623
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-282861 | Film No.: 251556169
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)